Literature DB >> 16939548

Characteristics and smoking cessation outcomes of patients returning for repeat tobacco dependence treatment.

E S Han1, J Foulds, M B Steinberg, K K Gandhi, B West, D L Richardson, S Zelenetz, J Dasika.   

Abstract

Previous studies of tobacco dependence treatment have reported very low cessation rates among smokers who relapse and return to make a subsequent formal attempt to quit. This retrospective cohort study examined 1745 patients who attended a tobacco dependence clinic between 2001 and 2005, and the characteristics and outcomes of those who relapsed and returned for repeat treatment. Patients who returned for repeat treatment showed higher markers of nicotine dependence and were more likely to have a history of treatment for mental health problems than patients who attended the clinic for only one treatment episode. Among patients who relapsed and returned for repeat treatment, the 26-week abstinence rates were similar for each consecutive quit attempt (23%, 22% and 20%). Clinicians should encourage smokers who relapse after an initial treatment episode to return for treatment, and repeat treatment should focus on addressing high nicotine dependence and potentially co-occurring mental health problems in order to improve cessation outcomes.

Entities:  

Mesh:

Year:  2006        PMID: 16939548     DOI: 10.1111/j.1742-1241.2006.01077.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  8 in total

1.  Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatment.

Authors:  D F Heitjan; D A Asch; Riju Ray; Margaret Rukstalis; Freda Patterson; C Lerman
Journal:  Pharmacogenomics J       Date:  2008-03-18       Impact factor: 3.550

Review 2.  Varenicline for tobacco dependence: panacea or plight?

Authors:  Jill M Williams; Michael B Steinberg; Marc L Steinberg; Kunal K Gandhi; Rajiv Ulpe; Jonathan Foulds
Journal:  Expert Opin Pharmacother       Date:  2011-06-06       Impact factor: 3.889

3.  The impact of repeated cycles of pharmacotherapy on smoking cessation: a longitudinal cohort study.

Authors:  A Paula Cupertino; Jo A Wick; Kimber P Richter; Laura Mussulman; Niaman Nazir; Edward F Ellerbeck
Journal:  Arch Intern Med       Date:  2009-11-09

4.  Smokers with behavioral health comorbidity should be designated a tobacco use disparity group.

Authors:  Jill M Williams; Marc L Steinberg; Kim Gesell Griffiths; Nina Cooperman
Journal:  Am J Public Health       Date:  2013-07-18       Impact factor: 9.308

5.  Maternal cigarette smoke exposure contributes to glucose intolerance and decreased brain insulin action in mice offspring independent of maternal diet.

Authors:  Hui Chen; Miguel A Iglesias; Vanni Caruso; Margaret J Morris
Journal:  PLoS One       Date:  2011-11-04       Impact factor: 3.240

6.  Using Diverse Communication Strategies to Re-Engage Relapsed Tobacco Quitline Users in Treatment, New York State, 2014.

Authors:  Beatriz Carlini; Lyndsay Miles; Suzanne Doyle; Paula Celestino; James Koutsky
Journal:  Prev Chronic Dis       Date:  2015-10-22       Impact factor: 2.830

7.  Scientific Evidence for the Addictiveness of Tobacco and Smoking Cessation in Tobacco Litigation.

Authors:  Sungwon Roh
Journal:  J Prev Med Public Health       Date:  2018-01

8.  Factors Predicting Client Re-Enrollment in Tobacco Cessation Services in a State Quitline.

Authors:  Uma S Nair; Benjamin R Brady; Patrick A O'Connor; Melanie L Bell
Journal:  Prev Chronic Dis       Date:  2018-10-18       Impact factor: 2.830

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.